Jean-Marie Michot, MD, discusses the OLYMPIA-3 study investigating odronextamab plus CHOP in previously untreated diffuse large B-cell lymphoma.
Jean-Marie Michot, MD
Advertisement
Jean-Marie Michot, MD, is a medical doctor in the Department of Hematology and Innovative Drugs at the Institut de Cancérologie Gustave Roussy.
Articles by Jean-Marie Michot, MD
Jean-Marie Michot, MD, discusses the examination of CC-99282 in relapsed/refractory non–Hodgkin lymphoma.
Advertisement
Latest Updated Articles
Dr Michot on the Importance of the OLYMPIA-3 Study of Odronextamab Plus Chemo in DLBCLPublished: December 8th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
2
Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma
3
Immune-Targeting Vaccine Shows Promise Intercepting Cancer in Patients With Lynch Syndrome
4
FDA Grants Orphan Drug Designation to Gotistobart in Squamous NSCLC
5